Foreign Pharmacy Graduate Equivalency Examination Prep Test

119 Questions

SettingsSettingsSettings
Please wait...
Pharmacy Quizzes & Trivia

.


Questions and Answers
  • 1. 
    • A. 

      Phenylbutazone

    • B. 

      Ketoconazol

    • C. 

      Amphotericin B

    • D. 

      Natamycin

  • 2. 
    • A. 

      Phenylbutazone

    • B. 

      Ketoconazol

    • C. 

      Amphotericin B

    • D. 

      Natamycin

  • 3. 
    • A. 

      Phenylbutazone

    • B. 

      Ketoconazol

    • C. 

      Amphotericin B

    • D. 

      Natamycin

  • 4. 
    • A. 

      Phenylbutazone

    • B. 

      Ketoconazol

    • C. 

      Amphotericin B

    • D. 

      Natamycin

  • 5. 
    • A. 

      Nonsteroidal anti-inflammatory

    • B. 

      Antifungal drug used to prevent and treat fungal skin infections

    • C. 

      Polyene antifungal drug, often used intravenously for systemic fungal infections

    • D. 

      Naturally occurring antifungal agent produced during fermentation by the bacterium Streptomyces natalensis

  • 6. 
    • A. 

      Nonsteroidal anti-inflammatory

    • B. 

      Antifungal drug used to prevent and treat fungal skin infections

    • C. 

      Polyene antifungal drug, often used intravenously for systemic fungal infections

    • D. 

      Naturally occurring antifungal agent produced during fermentation by the bacterium Streptomyces natalensis

  • 7. 
    • A. 

      Nonsteroidal anti-inflammatory

    • B. 

      Antifungal drug used to prevent and treat fungal skin infections

    • C. 

      Polyene antifungal drug, often used intravenously for systemic fungal infections

    • D. 

      Naturally occurring antifungal agent produced during fermentation by the bacterium Streptomyces natalensis

  • 8. 
    • A. 

      Nonsteroidal anti-inflammatory

    • B. 

      Antifungal drug used to prevent and treat fungal skin infections

    • C. 

      Polyene antifungal drug, often used intravenously for systemic fungal infections

    • D. 

      Naturally occurring antifungal agent produced during fermentation by the bacterium Streptomyces natalensis

  • 9. 
    • A. 

      Aminopycine

    • B. 

      Clothrimazole

    • C. 

      Nystatin

    • D. 

      Nafcillin

    • E. 

      Ceftazidime

  • 10. 
    • A. 

      Aminopycine

    • B. 

      Clothrimazole

    • C. 

      Nystatin

    • D. 

      Nafcillin

    • E. 

      Ceftazidime

  • 11. 
    • A. 

      Aminopycine

    • B. 

      Clothrimazole

    • C. 

      Nystatin

    • D. 

      Nafcillin

    • E. 

      Ceftazidime

  • 12. 
    • A. 

      Aminopycine

    • B. 

      Clothrimazole

    • C. 

      Nystatin

    • D. 

      Nafcillin

    • E. 

      Ceftazidime

  • 13. 
    • A. 

      Aminopycine

    • B. 

      Clothrimazole

    • C. 

      Nystatin

    • D. 

      Nafcillin

    • E. 

      Ceftazidime

  • 14. 
    • A. 

      Pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis

    • B. 

      Antifungal medication commonly used in the treatment of fungal infections (of both humans and other animals) such as vaginal yeast infections, oral thrush, and ringworm. It is also used to treat athlete's foot and the jock itch.

    • C. 

      Polyene antifungal medication to which many molds and yeast infections are sensitive, including Candida. Due to its toxicity profile, there are currently no injectable formulations of this drug on the US market.However, it may be safely given orally as well as applied topically due to its minimal absorption through mucocutaneous membranes such as the gut and the skin

    • D. 

      Narrow-spectrum[1] beta-lactam antibiotic[2] of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, in particular, species of staphylococci that are resistant to other penicillins.

    • E. 

      Third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa

  • 15. 
    • A. 

      Pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis

    • B. 

      Antifungal medication commonly used in the treatment of fungal infections (of both humans and other animals) such as vaginal yeast infections, oral thrush, and ringworm. It is also used to treat athlete's foot and the jock itch.

    • C. 

      Polyene antifungal medication to which many molds and yeast infections are sensitive, including Candida. Due to its toxicity profile, there are currently no injectable formulations of this drug on the US market.However, it may be safely given orally as well as applied topically due to its minimal absorption through mucocutaneous membranes such as the gut and the skin

    • D. 

      Narrow-spectrum[1] beta-lactam antibiotic[2] of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, in particular, species of staphylococci that are resistant to other penicillins.

    • E. 

      Third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa

  • 16. 
    • A. 

      Pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis

    • B. 

      Antifungal medication commonly used in the treatment of fungal infections (of both humans and other animals) such as vaginal yeast infections, oral thrush, and ringworm. It is also used to treat athlete's foot and the jock itch.

    • C. 

      Polyene antifungal medication to which many molds and yeast infections are sensitive, including Candida. Due to its toxicity profile, there are currently no injectable formulations of this drug on the US market.However, it may be safely given orally as well as applied topically due to its minimal absorption through mucocutaneous membranes such as the gut and the skin

    • D. 

      Narrow-spectrum[1] beta-lactam antibiotic[2] of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, in particular, species of staphylococci that are resistant to other penicillins.

    • E. 

      Third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa

  • 17. 
    • A. 

      Pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis

    • B. 

      Antifungal medication commonly used in the treatment of fungal infections (of both humans and other animals) such as vaginal yeast infections, oral thrush, and ringworm. It is also used to treat athlete's foot and the jock itch.

    • C. 

      Polyene antifungal medication to which many molds and yeast infections are sensitive, including Candida. Due to its toxicity profile, there are currently no injectable formulations of this drug on the US market.However, it may be safely given orally as well as applied topically due to its minimal absorption through mucocutaneous membranes such as the gut and the skin

    • D. 

      Narrow-spectrum[1] beta-lactam antibiotic[2] of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, in particular, species of staphylococci that are resistant to other penicillins.

    • E. 

      Third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa

  • 18. 
    • A. 

      Pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis

    • B. 

      Antifungal medication commonly used in the treatment of fungal infections (of both humans and other animals) such as vaginal yeast infections, oral thrush, and ringworm. It is also used to treat athlete's foot and the jock itch.

    • C. 

      Polyene antifungal medication to which many molds and yeast infections are sensitive, including Candida. Due to its toxicity profile, there are currently no injectable formulations of this drug on the US market.However, it may be safely given orally as well as applied topically due to its minimal absorption through mucocutaneous membranes such as the gut and the skin

    • D. 

      Narrow-spectrum[1] beta-lactam antibiotic[2] of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, in particular, species of staphylococci that are resistant to other penicillins.

    • E. 

      Third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa

  • 19. 
    First penicillins that adquired penicillase resistance  by steric hindrance at the alpha-carbon of the acyl group
    • A. 

      Methicillin and nafcillin

    • B. 

      Oxacillin, cloxacillin and dicloxacillin

    • C. 

      Ampicillin, amoxicillin and bacampicillin

    • D. 

      Carbenicillin and ticarcillin

    • E. 

      Azlocillin, mezlocillin and piperacillin

  • 20. 
    Penicillins that adquired penicillase resistance  by steric hindrance at the alpha-carbon of the acyl group by introduction of bulky groups.
    • A. 

      Methicillin and nafcillin

    • B. 

      Oxacillin, cloxacillin and dicloxacillin

    • C. 

      Ampicillin, amoxicillin and bacampicillin

    • D. 

      Carbenicillin and ticarcillin

    • E. 

      Azlocillin, mezlocillin and piperacillin

  • 21. 
    Penicillins that adquired extended spectrum of activity by introduction of a polar group(acidic) into alpha-position of the side chain benzyl carbon atom of oenicillin G.
    • A. 

      Methicillin and nafcillin

    • B. 

      Oxacillin, cloxacillin and dicloxacillin

    • C. 

      Ampicillin, amoxicillin and bacampicillin

    • D. 

      Carbenicillin and ticarcillin

    • E. 

      Azlocillin, mezlocillin and piperacillin

  • 22. 
    First penicillins that adquired extended spectrum of activity by introduction of a alpha-acylureido group into alpha-position of the side chain benzyl carbon atom of oenicillin G.
    • A. 

      Methicillin and nafcillin

    • B. 

      Oxacillin, cloxacillin and dicloxacillin

    • C. 

      Ampicillin, amoxicillin and bacampicillin

    • D. 

      Carbenicillin and ticarcillin

    • E. 

      Azlocillin, mezlocillin and piperacillin

  • 23. 
    Penicillins that adquired extended spectrum of activity by introduction of a polar group(amino) into alpha-position of the side chain benzyl carbon atom of penicillin G.
    • A. 

      Methicillin and nafcillin

    • B. 

      Oxacillin, cloxacillin and dicloxacillin

    • C. 

      Ampicillin, amoxicillin and bacampicillin

    • D. 

      Carbenicillin and ticarcillin

    • E. 

      Azlocillin, mezlocillin and piperacillin

  • 24. 
    margination
    • A. 

      Process in which leukocytes relocate from their normal central location in the bloodstream to th eperiphery along the endothelium wall

    • B. 

      Cascade that leads to trhombin formation, which converts fibrinogen to fibrin, leading to clot formation

    • C. 

      Leads to the production of a peptidethat causes vascular dilation and increases permeability

    • D. 

      Conversion of plasminogen into plasmin for degradation of fibrin clots and activation of the complement cascade

    • E. 

      Produces proteins that mediates inflamation causing vasodilation, increasing vascular permeability , promoting chemotaxis and phagocytosis and initiatiing hystamine release

  • 25. 
    coagulation
    • A. 

      Process in which leukocytes relocate from their normal central location in the bloodstream to th eperiphery along the endothelium wall

    • B. 

      Cascade that leads to trhombin formation, which converts fibrinogen to fibrin, leading to clot formation

    • C. 

      Leads to the production of a peptidethat causes vascular dilation and increases permeability

    • D. 

      Conversion of plasminogen into plasmin for degradation of fibrin clots and activation of the complement cascade

    • E. 

      Produces proteins that mediates inflamation causing vasodilation, increasing vascular permeability , promoting chemotaxis and phagocytosis and initiatiing hystamine release